CRISPR/Cas9 technology deleted the nucleotide sequence (SQKLAQV) corresponding to amino acids 91-97 (91del7). This 91-del7 in-frame deletion within the N-terminal intracellular tail of the protein is one variant among about 35 potential pathogenic mutations identified in idiopathic infantile hypercalcemia patients. (J:338295)